National Bank of Canada
NVO

National Bank of Canada’s Novo Nordisk NVO Stock Holding History

National Bank of Canada’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.04M Buy
+1,916
New +$90.8K 0.01% 779
2025
Q1 		– Sell
-4,500
Closed -$38.7M – 3064
2024
Q4 		$38.7M Buy
+4,500
New +$487K 0.04% 370
2024
Q2 		– Sell
-2,213
Closed -$28.4M – 2790
2024
Q1 		$28.4M Buy
+2,213
New +$263K 0.04% 324

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

National Bank of Canada's NVO Position: Q1 2026 in Review

National Bank of Canada reduced its Novo Nordisk (NVO) stake by 67% in Q1 2026, selling an estimated $68.2M and leaving 710,082 shares worth $26.1M. The position accounts for 0.02% of the portfolio, ranked #419.

National Bank of Canada first reported a position in NVO in Q4 2021 and has held it in 18 quarters since. The position peaked at $109M in Q4 2025. 1,276 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • National Bank of Canada held 710,082 shares of Novo Nordisk worth $26.1M as of Q1 2026.
  • National Bank of Canada sold 1,438,959 Novo Nordisk shares in Q1 2026, an estimated $68.2M.
  • Novo Nordisk made up 0.02% of National Bank of Canada's portfolio in Q1 2026, its #419 holding.
  • National Bank of Canada first reported a position in Novo Nordisk in Q4 2021 and has held it in 18 quarters since.
  • National Bank of Canada's Novo Nordisk position peaked at $109M in Q4 2025.
  • 1,276 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.